原发性胆汁性胆管炎高危因素的研究进展

廖海玲; 杨晋辉

doi:10.3969/j.issn.1001-5256.2020.09.049

原发性胆汁性胆管炎高危因素的研究进展

DOI: 10.3969/j.issn.1001-5256.2020.09.049

昆明医科大学第二附属医院消化内科

详细信息

中图分类号: R575.7
计量
- 文章访问数: 770
- HTML全文浏览量: 38
- PDF下载量: 139
- 被引次数: 0
出版历程
- 出版日期: 2020-09-20

Research advances in high-risk factors for primary biliary cholangitis

Department of Gastroenterology, The Second Affiliated Hospital of Kunming Medical University

摘要

摘要:
原发性胆汁性胆管炎(PBC)是一种由遗传易感性和环境触发因素共同作用引起的多因素疾病。在已知的发病危险因素中,环境因素主要通过对线粒体的免疫耐受产生破坏而引发疾病。而随着研究的深入,尤其是全基因组关联研究技术的应用,发现了一些可能导致该病的危险基因,如人类白细胞抗原基因IL和X染色体单体等。对PBC的高危因素如细菌、病毒感染以及遗传基础等方面的进展进行了阐述。
- 胆管炎,硬化性 /
- 危险因素
Abstract:
Primary biliary cholangitis( PBC) is a multifactorial disease caused by the combined effect of genetic susceptibility and environmental triggers. Among the known risk factors for PBC,environmental factors mainly cause the onset of the disease by disrupting mitochondrial immune tolerance. With the deepening of research,especially the application of genome-wide association study technology,some dangerous genes have been found,such as human leukocyte antigen gene IL and X chromosome monomer. This article reviews the research advances in high-risk factors for PBC.
- cholangitis,sclerosing /
- risk factors

HTML全文

参考文献(40)

[1] GERSHWIN ME,MACKAY IR. The causes of primary biliary cirrhosis:Convenient and inconvenient truths[J]. Hepatology,2008,47(2):737-745.

[2] PRINCE MI,CHETWYND A,CRAIG WL,et al. Asymptomatic primary biliary cirrhosis:Clinical features, prognosis, and symptom progression in a large population based cohort[J].Gut,2004,53(6):865-870.

[3] MA WT,CHANG C,GERSHWIN ME,et al. Development of autoantibodies precedes clinical manifestations of autoimmune diseases:A comprehensive review[J]. J Autoimmun,2017,83:95-112.

[4] TERZIROLI BERETTA-PICCOLI B,STIRNIMANN G,CERNY A,et al. Geoepidemiology of primary biliary cholangitis:Lessons from Switzerland[J]. Clin Rev Allergy Immunol,2018,54(2):295-306.

[5] TANAKA A,LEUNG PS,GERSHWIN ME. Environmental basis of primary biliary cholangitis[J]. Exp Biol Med(Maywood),2018,243(2):184-189.

[6] JURAN BD,LAZARIDIS KN. Environmental factors in primary biliary cirrhosis[J]. Semin Liver Dis,2014,34(3):265-272.

[7] LEUNG PS,CHOI J,YANG G,et al. A contemporary perspective on the molecular characteristics of mitochondrial autoantigens and diagnosis in primary biliary cholangitis[J]. Expert Rev Mol Diagn,2016,16(6):697-705.

[8] WANG J,BUDAMAGUNTA MS,VOSS JC,et al. Antimitochondrial antibody recognition and structural integrity of the inner lipoyl domain of the E2 subunit of pyruvate dehydrogenase complex[J]. J Immunol,2013,191(5):2126-2133.

[9] AGMON-LEVIN N,KATZ BS,SHOENFELD Y. Infection and primary biliary cirrhosis[J]. Isr Med Assoc J,2009,11(2):112-115.

[10] WANG J,YANG G,DUBROVSKY AM,et al. Xenobiotics and loss of tolerance in primary biliary cholangitis[J]. World J Gastroenterol,2016,22(1):338-348.

[11] BOGDANOS DP,VERGANI D. Bacteria and primary biliary cirrhosis[J]. Clin Rev Allergy Immunol,2009,36(1):30-39.

[12] LEUNG PS,WANG J,NAIYANETR P,et al. Environment and primary biliary cirrhosis:Electrophilic drugs and the induction of AMA[J]. J Autoimmun,2013,41:79-86.

[13] BURROUGHS AK,ROSENSTEIN IJ,EPSTEIN O,et al. Bacteriuria and primary biliary cirrhosis[J]. Gut,1984,25(2):133-137.

[14] FLOREANI A,BASSENDINE MF,MITCHISON H,et al. No specific association between primary biliary cirrhosis and bacteriuria?[J]. J Hepatol,1989,8(2):201-207.

[15] HOWEL D,FISCHBACHER CM,BHOPAL RS,et al. An exploratory population-based case-control study of primary biliary cirrhosis[J]. Hepatology,2000,31(5):1055-1060.

[16] PRINCE MI,DUCKER SJ,JAMES OF. Case-control studies of risk factors for primary biliary cirrhosis in two United Kingdom populations[J]. Gut,2010,59(4):508-512.

[17] PARIKH-PATEL A,GOLD EB,WORMAN H,et al. Risk factors for primary biliary cirrhosis in a cohort of patients from the united states[J]. Hepatology,2001,33(1):16-21.

[18] GERSHWIN ME,SELMI C,WORMAN HJ,et al. Risk factors and comorbidities in primary biliary cirrhosis:a controlled interview-based study of 1032 patients[J]. Hepatology,2005,42(5):1194-1202.

[19] CORPECHOT C,CHRTIEN Y,CHAZOUILLRES O,et al.Demographic,lifestyle,medical and familial factors associated with primary biliary cirrhosis[J]. J Hepatol,2010,53(1):162-169.

[20] TANAKA A,LEUNG P,GERSHWIN ME. Pathogen infections and primary biliary cholangitis[J]. Clin Exp Immunol,2019,195(1):25-34.

[21] BURROUGHS AK,BUTLER P,STERNBERG MJ,et al. Molecular mimicry in liver disease[J]. Nature,1992,358(6385):377-378.

[22] TAKEUCHI M,HAMANA K,HIRAISHI A. Proposal of the genus Sphingomonas sensu stricto and three new genera,Sphingobium,Novosphingobium and Sphingopyxis, on the basis of phylogenetic and chemotaxonomic analyses[J]. Int J Syst Evol Microbiol,2001,51(Pt 4):1405-1417.

[23] KAPLAN MM. Novosphingobium aromaticivorans:A potential initiator of primary biliary cirrhosis[J]. Am J Gastroenterol,2004,99(11):2147-2149.

[24] NILSSON HO,TANEERA J,CASTEDAL M,et al. Identification of Helicobacter pylori and other Helicobacter species by PCR,hybridization,and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis[J]. J Clin Microbiol,2000,38(3):1072-1076.

[25] LJUNGH A,NILSSON HO,WADSTRM T,et al. Microbes as trigger for primary biliary cirrhosis and primary sclerosing cholangitis[J]. Dig Liver Dis,2005,37(10):803-804.

[26] BOGDANOS DP,SMYK DS,RIGOPOULOU EI,et al. Infectomics and autoinfectomics:A tool to study infectious-induced autoimmunity[J]. Lupus,2015,24(4-5):364-373.

[27] WAKABAYASHI K,LIAN ZX,MORITOKI Y,et al. IL-2 receptor alpha(-/-)mice and the development of primary biliary cirrhosis[J]. Hepatology,2006,44(5):1240-1249.

[28] ABDULKARIM AS,PETROVIC LM,KIM WR,et al. Primary biliary cirrhosis:An infectious disease caused by Chlamydia pneumoniae?[J]. J Hepatol,2004,40(3):380-384.

[29] LIU HY,FAN LY,TU XQ,et al. The relationship between Chlamydia pneumoniae infection and primary biliary cirrhosis[J]. Chin J Hepatol,2004,12(9):546-548.(in Chinese)刘海英，范列英，屠小卿，等．肺炎衣原体感染与原发性胆汁性肝硬化的相关性研究[J]．中华肝脏病杂志，2004,12(9):546-548.

[30] MASON AL. Is PBC a viral infectious disease?[J]. Best Pract Res Clin Gastroenterol,2018,34-35:27-39.

[31] MORSHED SA,NISHIOKA M,SAITO I,et al. Increased expression of Epstein-Barr virus in primary biliary cirrhosis patients[J]. Gastroenterol Jpn,1992,27(6):751-758.

[32] WALDEN HR,KIRBY JA,YEAMAN SJ,et al. Xenobiotic incorporation into pyruvate dehydrogenase complex can occur via the exogenous lipoylation pathway[J]. Hepatology,2008,48(6):1874-1884.

[33] LIU SP,BIAN ZH,ZHAO ZB,et al. Animal models of autoimmune liver diseases:A comprehensive review[J]. Clin Rev Allergy Immunol,2020,58(2):252-271.

[34] AMANO K,LEUNG PS,RIEGER R,et al. Chemical xenobiotics and mitochondrial autoantigens in primary biliary cirrhosis:Identification of antibodies against a common environmental,cosmetic,and food additive,2-octynoic acid[J]. J Immunol,2005,174(9):5874-5883.

[35] OHBA K,OMAGARI K,KINOSHITA H,et al. Primary biliary cirrhosis among atomic bomb survivors in Nagasaki,Japan[J]. J Clin Epidemiol,2001,54(8):845-850.

[36] ALA A,STANCA CM,BU-GHANIM M,et al. Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites[J]. Hepatology,2006,43(3):525-531.

[37] SELMI C,MAYO MJ,BACH N,et al. Primary biliary cirrhosis in monozygotic and dizygotic twins:Genetics,epigenetics,and environment[J]. Gastroenterology,2004,127(2):485-492.

[38] GLEICHER N,BARAD DH. Gender as risk factor for autoimmune diseases[J]. J Autoimmun,2007,28(1):1-6.

[39] LI M,ZHENG H,TIAN QB,et al. HLA-DR polymorphism and primary biliary cirrhosis:Evidence from a meta-analysis[J]. Arch Med Res,2014,45(3):270-279.

[40] QIU F,TANG R,ZUO X,et al. A genome-wide association study identifies six novel risk loci for primary biliary cholangitis[J]. Nat Commun,2017,8:14828.

施引文献

资源附件(0)

访问统计